MARKET

PLUR

PLUR

Pluri Inc
NASDAQ
1.120
-0.060
-5.08%
Pre Market: 1.230 +0.11 +9.82% 08:45 11/11 EST
OPEN
1.190
PREV CLOSE
1.180
HIGH
1.190
LOW
1.050
VOLUME
251
TURNOVER
0
52 WEEK HIGH
4.865
52 WEEK LOW
0.8500
MARKET CAP
14.12M
P/E (TTM)
-0.4581
1D
5D
1M
3M
1Y
5Y
1D
Why Greenfire Resources Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket
Benzinga · 2d ago
Weekly Report: what happened at PLUR last week (1102-1106)?
Weekly Report · 2d ago
Weekly Report: what happened at PLUR last week (1026-1030)?
Weekly Report · 11/02 09:06
Pluri Forms Strategic U.S. Regenerative Medicine Partnership
TipRanks · 10/30 13:01
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 10/27 21:05
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 10/27 12:05
Pluri and ZEO ScientifiX Partner to Expand U.S. Manufacturing and Commercial Platform
TipRanks · 10/26 11:30
Pluri And ZEO ScientifiX Announce Strategic Agreement To Expand Parties US Manufacturing And Commercialization Platform Serving Regenerative Medicine, Aesthetics, Wellness, And Longevity Markets
Benzinga · 10/26 11:07
More
About PLUR
Pluri Inc., formerly known as Pluristem Therapeutics Inc., is an Israel-headquartered company engaged in the research and provision of cell-based products directed for a range of industries. The Company is focused on researching and developing cell transformation and 3D cell expansion technologies that allow mass production of cells. The products of the Company are used for the pharmaceutical industry as well as for food technology, agriculture technology, and cell-based materials. In the pharmaceutical sector, the Company's preclinical and clinical programs explore multiple therapeutic areas such as vascular disease, inflammation-related conditions, muscle injuries, and hematological disorders. In the food sector, the Firm produces cultivated meat, cultivated fish, and seafood, as well as plant-based products. In agriculture, the Company develops alternative farming methods. The Company has a portfolio of over 140 granted patents in approximately 52 countries.

Webull offers Pluri Inc stock information, including NASDAQ: PLUR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PLUR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PLUR stock methods without spending real money on the virtual paper trading platform.